Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Grenier, , Pauline,
DOB: 03-MAY-1971 (Age: 54)
Gender: female
Address:
114, avenue Georges
71110 Caron (France)
ID: 6776-872657-1 (ECI)
Report
Date: 17-MAR-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Hôpital du Creusot - Site Foch
71200 Le Creusot (France)
Specimen
Collected: 17-MAR-2025

Chemistry

Test 17-MAR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 99.8 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.5 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 103.5 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.7 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The results show mildly elevated HbA1c and fasting glucose, indicating impaired glucose metabolism or possible early diabetes. Renal function, electrolytes, and other parameters are within normal limits. Recommend clinical correlation and consideration of further evaluation or management for glycemic control.